A Study to Evaluate the Efficacy of the Nasal Antiseptic, PrevinC, When Administered for the RiskReduction of Rhinitis in Subjects Who Work for Child Day Care Centers

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Study Classification

INTERVENTIONAL

Study Start Date

2005-02-28

Study Completion Date

2005-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The hypothesis was to establish whether the use of PrevinC administered nasally 2-3 times a day will prevent upper respiratory infections in otherwise healthy adults working in child day care centers.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Use of Antibiotic Sinonasal Rinse After Sinus Surgery

NCT02218307

Chronic Rhinosinusitis

COMPLETED PHASE4

Effects of Pleconaril Nasal Spray on Common Cold Symptoms and Asthma Exacerbations Following Rhinovirus Exposure (Study P04295)

NCT00394914

Asthma Common Cold Picornavirus Infection +1 more

COMPLETED PHASE2

Sinusitis in Children and the Nasopharyngeal Microbiome

NCT01492868

Sinusitis

COMPLETED

Immediate Effect of Proponent-Nasal-Spray on Unspecific Discomfort in the Nose

NCT03251066

Unspecified Disorder of Nose and Nasal Sinuses

COMPLETED NA

Topical Antibiotic Use In Chronic Rhinosinusitis A Double-Blinded, Randomized, Placebo Controlled Study

NCT00669799

Rhinosinusitis

WITHDRAWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Upper Respiratory Infections

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Intervention Model

CROSSOVER

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PrevinC

PrevinC contains isopropyl alcohol, sesame oil, aloe vera oil extract, and lemon oil.

Group Type EXPERIMENTAL

PrevinC

Intervention Type OTHER

Control solution

The control solution (distilled water and lemon oil) was similar in color, oily consistency and odor to that of PrevinC.

Group Type PLACEBO_COMPARATOR

placebo

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

PrevinC

Intervention Type OTHER

placebo

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject must provide written informed consent prior to the conduct of any study
* Male or female
* 18-65 years of age
* Inclusive
* Employed by one of seven selected Day Care Centers

Exclusion Criteria

* Recent symptoms of upper respiratory infection, respiratory disease
* Received medication for colds or allergies within 3 weeks of enrolling
* Had nasal surgery within 2 months of enrolling
* Had a pierced nose or wore nose jewelry

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No